BCG vaccine: efficacy and indications for vaccination and revaccination.
about
Advances and hurdles on the way toward a leprosy vaccine.Combination chemoprophylaxis and immunoprophylaxis in reducing the incidence of leprosyPrevention and control of neglected tropical diseases: overview of randomized trials, systematic reviews and meta-analysesRecombinant Mycobacterium bovis BCG as an HIV vaccine vector.Safety and immunogenicity of boosting BCG vaccinated subjects with BCG: comparison with boosting with a new TB vaccine, MVA85AInfluence of advanced age on Mycobacterium bovis BCG vaccination in guinea pigs aerogenically infected with Mycobacterium tuberculosisComparative evaluation of booster efficacies of BCG, Ag85B, and Ag85B peptides based vaccines to boost BCG induced immunity in BALB/c mice: a pilot study.Protection of mice from Mycobacterium tuberculosis by ID87/GLA-SE, a novel tuberculosis subunit vaccine candidate.Effects of low birth weight on time to BCG vaccination in an urban poor settlement in Nairobi, Kenya: an observational cohort study.Assessment of immunological markers and booster effects of Ag85B peptides, Ag85B, and BCG in blood of BCG vaccinated children: a preliminary report.Construction of eukaryotic expression vectors encoding CFP-10 and ESAT-6 genes and their potential in lymphocyte proliferationBCG and New Preventive Tuberculosis Vaccines: Implications for Healthcare Workers.Neonatal vaccination with bacille Calmette-Guérin promotes the dendritic development of hippocampal neurons.Central nervous system tuberculosis: pathogenesis and clinical aspects.III Brazilian Thoracic Association Guidelines on tuberculosis.Vaccine research and development: tuberculosis as a global health threat.CHO expressed recombinant human lactoferrin as an adjuvant for BCG.Vaccination in the prevention of infectious respiratory diseases in adults.Bacillus Calmette-Guerin vaccine-mediated neuroprotection is associated with regulatory T-cell induction in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease.CD14-159C/T polymorphism in the development of delayed skin hypersensitivity to tuberculin.Next-Generation Vaccines Based on Bacille Calmette-Guérin.Bacterial meningitis and living conditions.Severe combined immunodeficiency: a cohort of 40 patients.
P2860
Q22305432-737551F4-FBB7-49FE-BBA2-505A64A285BFQ26749927-BB998BB2-DD7E-4A48-80A3-22AD01950E48Q26864627-4E5BF2E7-A243-4928-B448-501CB08F7092Q30387447-08EA3933-7546-4757-A66C-A5A8D07DD6D4Q33468451-83701EBC-09DD-477B-875C-F7B81433BAD9Q34190011-4E00FC01-B677-4A62-9993-6AAEF03C3BBEQ35035635-C99F1436-B51B-4535-89D6-86DEF8F709FBQ35301384-D08565A1-8E87-489F-90E5-ED66953646D1Q35520015-387E5A8E-5CAD-4950-96CD-C35B85736D92Q36547958-FF22FFF3-7E81-453D-857E-37AC98C611F4Q36589524-BC2BE6DD-D78A-4995-9C1D-9396250D5343Q36838289-29E54835-3C9F-4A82-B0CE-18E79838C8BEQ37130270-F631FDF0-1084-4D39-B6D0-2398F5FA5635Q37133651-DAE82FD6-61AD-4386-8817-542EE32C3708Q37634019-0C20C9E3-433D-4C0F-8A2B-7CB841E7C705Q40059597-F60D12D5-2475-40F9-AB5E-5D2F84C80B4CQ41028714-55145E6B-1388-4752-8146-9D32D8FE23F0Q42210967-3C74105D-0A20-4E76-9F0E-390AC6BB1361Q44578009-0C72ED92-40B6-4BA7-9156-B3CF7F710A9CQ47187631-FCC389BF-3E86-4350-A596-540A9FC59576Q49829375-3B4FC8F7-0DD4-4FDB-B12F-8A4A4B4353DEQ51557714-F8BC5772-00B8-4C77-800B-36AAFF55A20BQ53509911-9A5A5546-C9F7-4A77-94DB-48527F22B2DA
P2860
BCG vaccine: efficacy and indications for vaccination and revaccination.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
BCG vaccine: efficacy and indications for vaccination and revaccination.
@ast
BCG vaccine: efficacy and indications for vaccination and revaccination.
@en
type
label
BCG vaccine: efficacy and indications for vaccination and revaccination.
@ast
BCG vaccine: efficacy and indications for vaccination and revaccination.
@en
prefLabel
BCG vaccine: efficacy and indications for vaccination and revaccination.
@ast
BCG vaccine: efficacy and indications for vaccination and revaccination.
@en
P356
P1433
P1476
BCG vaccine: efficacy and indications for vaccination and revaccination.
@en
P2093
Arlan A Ferreira
Susan M Pereira
P304
P356
10.2223/JPED.1499
P433
P577
2006-07-01T00:00:00Z